Check out the companies making headlines in midday trading. Quantum stocks — Quantum computing stocks dropped after Meta Platforms CEO Mark Zuckerberg became the latest high-profile executive to ease expectations for the technology. Rigetti Computing dropped 27%, while D-Wave Quantum shed 32%. The Defiance Quantum & AI ETF lost 2.5%. Nvidia , chip stocks — Popular semiconductor stocks declined after the Biden administration revealed new AI chip export caps. Nvidia lost more than 2%, while the VanEck Semiconductor ETF dropped 1.4%. Micron Technology shed nearly 5%. Moderna — Shares shed more than 20% after the vaccine maker cut its 2025 sales guidance by about $1 billion to range between $1.5 billion and $2.5 billion. The company anticipates the majority of its revenue will come in the second half of the year. Crypto stocks — Stocks tied to cryptocurrencies fell as bitcoin slumped more than 3% and briefly dropped below the $90,000 mark. Coinbase fell nearly 5%, while Mara Holdings slipped nearly 7% and MicroStrategy fell 4%. Pinterest —Shares of the visual sharing platform fell 4% on the heels of Jefferies’ downgrade to hold. The bank described Pinterest’s growth as “underwhelming” and pulled down its forecasts for revenue and EBITDA in the 2025 fiscal year. Edison International — Shares dropped 13% as wildfires continued to ripple through Los Angeles. Officials are investigating whether infrastructure sites from its Southern California Edison subsidiary ignited a brush fire. E.l.f. Beauty — The cosmetics producer popped 4% on the back of Morgan Stanley’s upgrade to overweight from equal weight. The bank said e.l.f.’s valuation is more enticing after its pullback in the second half of 2024. Howard Hughes Holdings — The real estate developer’s shares jumped 9% after Bill Ackman proposed a merger deal that offers current holders $85 a share. Ackman proposed forming a new subsidiary of Pershing, which currently owns about 38% of Howard Hughes, that would merge with the real estate developer based in The Woodlands, Texas. Managed care stocks — Managed care names rose on Monday, following the U.S. government’s Friday proposal to increase its 2026 reimbursement rates for Medicare Advantage plans by an average total of 4.3%. Humana gained 8%, followed by a 6% rise in CVS Health and 4% gain in UnitedHealth . U.S. Steel — Shares popped 8% after CNBC reported that Cleveland Cliffs and Nucor are partnering for a potential takeover big after its deal after the White House blocked its deal to be acquired by Japan’s Nippon Steel. Both stocks rose about 4% each.’ Megacap technology — Megacap technology stocks dropped as U.S. Treasury yields pushed higher. Nvidia lost 2%, along with Apple and Meta Platforms . Microsoft and Alphabet fell about 1%. Intra-Cellular Therapies — The stock jumped 34% following the announcement that Johnson & Johnson will buy the drugmaker for $132 per share. That suggests a 39% premium to Friday’s closing price and values Intra-Cellular Therapies at $14.6 billion. Shares of Johnson & Johnson were flat. Abercrombie & Fitch – The stock plunged about 18% after the clothing retailer’s updated fourth-quarter forecast disappointed investors. The company now anticipates net sales for the period to grow between 7% and 8%, up from its prior guidance of growth between 5% and 7%. With those holiday expectations being lower than the numbers the company posted for the prior-year period, that could signal a slowdown in growth. Macy’s — The retail stock fell more than 7% after the company said it expected net sales for the fiscal fourth quarter to be near the low end of its previous guidance range. Macy’s said its comparable sales were “roughly flat” quarter to date, including a drag from locations that aren’t part of the company’s future plans. — CNBC’s Yun Li, Alex Harring, Sean Conlon, Lisa Han, Michelle Fox and Jesse Pound contributed reporting
BEIJING — China’s electric car market is headed for a sharp slowdown in 2025, according to analyst predictions, increasing pressure on companies trying to survive.
Sales of new energy vehicles, a category which includes battery-only and hybrid-powered cars, surged last year by 42% to nearly 11 million units, according to the China Passenger Car Association. Market leader BYD‘s NEV sales skyrocketed — up by more than 40% last year to nearly 4.3 million units, far above its internal target of at least 20% growth from 2023.
But looking ahead, HSBC analysts forecast only a 20% increase in China’s new energy vehicle sales this year, alongside heightened industry consolidation. They predict BYD unit sales growth of around 14%.
Strong sales volumes have enabled “strugglers and stragglers” to hang on despite falling margins, Yuqian Ding, head of China autos research at HSBC, said in a report last week. She pointed out that only BYD, Tesla and Li Auto made a profit in 2023.
“In our view, this situation is unsustainable and we expect the pace of industry consolidation to accelerate rapidly,” Ding said.
China’s mix of subsidies and consumer purchase incentives have supported the rapid growth of new energy vehicles in recent years.
Shenzhen-based laser display company Appotronics didn’t even have an autos business until it started making an in-car projector screen that began deliveries in China early last year. The company shipped more than 170,000 units last year.
But in a sign of a changing market, the company only expects similar volumes in 2025, Appotronics Chairman and CEO Li Yi told CNBC last week. He predicted the market wouldn’t pick back up until 2026.
“A lot of customers, the automakers, they’re not in a good financial state. They cut the R&D budget. That will definitely have a negative impact on this industry,” Li said, also noting overcapacity issues.
As automakers piled into China’s fast-growing electric car market, they began a price war in a bid to attract customers. Smartphone company Xiaomi launched its SU7 electric sedan last year at $4,000 less than Tesla’s Model 3, and with claims of a longer driving range.
“When BYD and Tesla cut prices, most rivals have little choice but to follow suit. This has clearly squeezed the overall profit pool in the auto industry, especially now that EVs have all the momentum,” HSBC’s Ding said, noting that BYD has a net profit margin of only 5%, less than the low teens for top automakers when the traditional fossil fuel car was at its peak.
NEV penetration of new cars sold had exceeded 50% by the second half of the year, association data showed.
Because of the high penetration rate, the growth rate of new NEV car sales will likely slow to 15% to 20% in 2025, according to Fitch Bohua analyst Wenyu Zhou and a team. They expect so-called smart features will increasingly become a major point of competition.
While the electric car market moderates its growth, Appotronics plans to bring a 4K-resolution projector to cars in China this year, along with a screen that has better contrast and privacy features, Li said.
As for the longer term, the company intends to spend the next two to three years on developing new, laser-based uses for car headlights, Li said. He added the company is in talks with Tesla for a projector-type product in a next-generation vehicle, but could not say more because of a non-disclosure agreement.
Cliff Asness, co-founder of AQR Capital Management, believes bitcoin is in a speculative bubble after the cryptocurrency’s swift rally carried it above $100,000 following the November presidential election.
“I’m on the bubble side, on net,” Asness said on CNBC’s “Money Movers” on Monday. “To move me off that, you really need not a price change, but a use case. That’s what could convince me to become maybe more of a crypto person when I find any use for it, aside from speculation and criminality.”
Asness said there are three uses for crypto that he has identified: speculation, use in war-torn countries and paying cyber ransom.
Bitcoin rallied 120% in 2024 after a huge year-end pop on the back of President-elect Donald Trump’s election. Investors hoped Trump would usher in a golden age of crypto, including supportive deregulation of the industry and a national strategic bitcoin reserve. The digital coin has dipped 3% in the new year, last trading near $90,000.
“There’s no fundamental trend for crypto because I don’t know what the fundamentals are, but there is a price trend,” Asness said. “So I would guess most trend followers who have it in their universe are actually long.”
Bitcoin over the past year.
Although Asness is bearish on crypto, he noted that he would not bet against it due to its volatility.
“I wouldn’t short crypto only because shorting things with 100% annual volatility can be a little scary. I think we’ve all discovered what concentrated shorts can do to a portfolio,” he added.
Asness co-founded AQR in 1998 after a stint at Goldman Sachs. He and his partners established the quant-driven firm’s investment philosophy at the University of Chicago’s Ph.D. program, focusing on value and momentum strategies.
Check out the companies making headlines before the bell. Quantum stocks — Quantum stocks tumbled on Monday morning, following comments from Mark Zuckerberg echoing Nvidia CEO Jensen Huang that quantum is at least a decade away from being a “useful paradigm.” Zuckerberg made the comments on a Friday episode of the “Joe Rogan Experience.” Shares of Rigetti Computing fell 25% and D-Wave Quantum tumbled around 16%, followed by an 8% decline in IonQ and a 9% slide in Quantum Computing . Managed care stocks — Managed care stocks rose after the U.S. government proposed on Friday an average total increase of 4.3% to its 2026 reimbursement rates for Medicare Advantage plans. Shares of Humana rose almost 6%, while UnitedHealth and CVS Health each added 3%. Boot Barn — The boot retailer popped about 4% after Boot Barn guided for third-quarter earnings per share of around $2.43 on Friday afternoon, higher than the $2.05 analysts polled by FactSet had previous expected. The company’s expected revenue of $608.2 million also came above the prior consensus of $593.4 million. Pinterest — Shares of the visual sharing platform slid 3% in the wake of Jefferies’ downgrade to hold. Jefferies also called the company’s growth “underwhelming” and lowered its forecasts for revenue and EBITDA in the 2025 fiscal year. Crypto stocks — Stocks tied to the price of bitcoin were lower as the cryptocurrency slid to about $90,000. Coinbase and MicroStrategy fell 4% each, in premarket trading. The bitcoin miner Mara Holdings lost 4% and Core Scientific retreated by 3%. Lululemon — Shares of the apparel company rose more than 3% after a holiday sales update showed strong demand . Lululemon raised its guidance for sales and earnings per share for the fourth quarter. The company also said it expects gross margin to expand year over year, while previous guidance called for the margin to narrow. Macy’s — Shares fell 2% after Macy’s issued a lackluster update to its fourth-quarter guidance . Revenue is expected to come in slightly below or at the lower end of previous guidance of $7.8 billion to $8.0 billion. Comparable sales are expected to be roughly flat quarter to date, compared with the consensus estimate of a 0.4% rise, according to FactSet. Abercrombie & Fitch — Shares of the clothing retailer plunged 11% in premarket trading even after Abercrombie raised its outlook for the fourth quarter on strong holiday sales expectations. The company now expects fourth-quarter net sales to grow between 7% and 8%, compared with previous guidance of 5% to 7% growth. Those holiday expectations are still lower than the year-ago period, however, suggesting a slowdown in growth. Howard Hughes Holdings — Shares of the real estate developer jumped 9% after Bill Ackman’s Pershing Square proposed a deal to form a new entity to merge with the real estate company, offering current holders $85 a share. Megacap tech stocks — Megacap tech stocks tumbled on Monday morning as U.S. Treasury yields rose, adding upon their losses from last week. Nvidia , Tesla and Palantir Technologies each lost around 3%, while Broadcom and Micron Technology shed approximately 2%. Moderna — The biotech firm plunged 20% after lowering its 2025 sales guidance by about $1 billion, citing potential headwinds in 2025. Moderna now expects this year’s revenue to fall between $1.5 billion and $2.5 billion, with the majority coming in the second half of the year. Intra-Cellular Therapies — The stock soared nearly 34% after Johnson & Johnson announced it will take over the neurological treatment company for $132 per share. That values Intra-Cellular Therapies at $14.6 billion. Shares of Johnson & Johnson were flat. — CNBC’s Michelle Fox, Alex Harring, Yun Li, Tanaya Macheel, Sarah Min, Jesse Pound and Pia Singh contributed reporting.